P01066 AF NFT

Bowman-Birk type proteinase inhibitor A-II

MOLNFT AF v1 smart contract in GenesisL1 blockchain: 
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
IPFS of NFT metadata: 
bafybeifooo7szh26voigrfafyf73gkexd3glca3kp6ky7rg6thgobtitru/metadata.json
IPFS of structure file: 
bafybeicbvp2o7eu5ojvvgpn3mdwshcqbfmtriggrgijnjvkj7lquy6kn7y/AF-P01066-F1-model_v2.pdb
First NFT owner address (eip-55): 
0x31C2b8Dda9af930b8C9df8eCc4E387b89CF5fc9A
First NFT owner address (bech32): 
genesis1x8pt3hdf47fshryalrkvfcu8hzw0tly6zdtfjr
Current NFT ID #183019 owner (web3):

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1

NFT id:
183019
Accession (UniProt):
P01066
Name::
Bowman-Birk type proteinase inhibitor A-II
Experimental Method:
Predicted structure
Sequence source:
ARACHIS HYPOGAEA

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT P01066 research and analysis (ICN3D with VR)

FASTA sequences

>sp|P01066|IBB1_ARAHY Bowman-Birk type proteinase inhibitor A-II OS=Arachis hypogaea OX=3818 PE=1 SV=1 EASSSSDDNVCCNGCLCDRRAPPYFECVCVDTFDHCPASCNSCVCTRSNPPQCRCTDKTQGRCPVTECRS